News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

$2.5 Million Department of Defense Grant Funds Development of Targeted Therapy for Triple-Negative Breast Cancer

Triple-negative breast cancer cell

Weill Cornell Medicine has received a $2.5 million, three-year grant from the Department of Defense (DoD) to develop therapies with fewer side effects for triple-negative breast cancer, one of the most aggressive and difficult-to-treat breast cancers. The highly competitive DoD Breast Cancer Research Program Breakthrough Award supports innovative projects with strong potential to transform breast cancer treatment.

Triple-negative breast cancer lacks three proteins—estrogen receptor, progesterone receptor and HER2—that many of today's targeted therapies attack, leaving many patients limited to chemotherapy as their primary treatment option.

Dr. Xiaojing Ma

Dr. Xiaojing Ma

2026 Excellence in Medical Education Awards

A group of people pose for a photo

More than 30 Weill Cornell Medicine faculty and staff were honored June 25 with Excellence in Medical Education Awards at a ceremony held on campus.

“It is an honor to celebrate the accomplishments of our honorees for their extraordinary contributions to the education mission and for making the Weill Cornell Medical College experience exceptional for our students,” said Dr. Joseph Safdieh, the Richard P. Cohen, M.D. Senior Associate Dean for Education at Weill Cornell Medicine, who presented the awards, which are given at the end of each academic year.

Trophies on a table with a red tablecloth

Excellence in Medical Education Award trophies

The winners represent a wide range of departments across the institution, with categories recognizing teaching, distinguished service and leadership. 

Phase 1 Curriculum

Essential Principles of Medicine – Part A

Jennifer Bassetti, M.D.
Aistant Professor of Clinical PediatricsEssential Principles of Medicine – Part B

Weill Cornell Medicine Scientist Receives Award for Research on New Ovarian Cancer Targets

Microscopic image of ovarian cancer cells, illustrated in purple

Dr. Dan Landau, the Bibliowicz Family Professor of Medicine, and a member of the Sandra and Edward Meyer Cancer Center and the Englander Institute for Precision Medicine at Weill Cornell Medicine, has received a Lotus Award from the Pershing Square Foundation for research aimed at uncovering new immunotherapy targets in ovarian cancer.

The Pershing Square Foundation supports ambitious cancer research projects, and since 2025 has been funding ovarian cancer research with three-year grants of $750,000, now called Lotus Awards. Awardees were selected for their scientific rigor, originality and potential to drive meaningful advances in a disease where progress is urgently needed. Dr. Landau is one of eight recipients this year.

“We’re grateful for this opportunity to develop new therapeutic perspectives to benefit patients with this deadly but relatively under-studied form of cancer,” said Dr. Landau, who is also a core faculty member of the New York Genome Center.